Turing Pharmaceuticals chief executive Martin Shkreli has gotten under the skin of Big Pharma’s bosses.
“He is not us,” Merck CEO Kenneth Frazier said during a panel at Forbes Healthcare Summit in New York on Thursday.
The executives, including leaders of Celgene, Pfizer, Regeneron and GlaxoSmithKline were discussing drug pricing shortly after Shkreli wrapped up a one-on-one interview.
